OWC PHARMACEUTICAL RESEARCH CORP. *Cannabis Research for Treatments*
Based in Israel Ticker [OTC : OWCP]
Overview
OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, PTSD, migraines, and of a unique delivery system.
Dr. Ben-Zion Weiner of TEVA was among the original investors in OWCP, and is advising the Company. Dr. Ben-Zion Weiner was Head of Global Research and Development at Teva Pharmaceutical Industries Ltd. for over three decades, including as Chief R&D Officer and as a member of the Teva Executive Committee.